Jones Financial Companies Lllp Grows Stock Holdings in Henry Schein, Inc. $HSIC

Key Points

• Jones Financial Companies Lllp significantly increased its stake in Henry Schein, Inc. by 24,351.3%, acquiring 540,112 shares during the first quarter, bringing its total ownership to 542,330 shares valued at approximately $37.14 million.
• Several institutional investors, including Steadfast Capital Management and Millennium Management, also made substantial investments in Henry Schein, revealing strong interest from hedge funds with 96.62% of the stock held by institutions.
• Analysts have mixed ratings for Henry Schein, with price targets ranging from $75.00 to $83.00, reflecting cautious optimism about the company's future performance despite a recent earnings miss.

Jones Financial Companies Lllp raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 24,351.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 542,330 shares of the company's stock after purchasing an additional 540,112 shares during the quarter. Jones Financial Companies Lllp owned 0.45% of Henry Schein worth $37,144,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Investment Management Corp VA ADV purchased a new stake in Henry Schein in the fourth quarter valued at $32,000. Rakuten Securities Inc. purchased a new stake in Henry Schein in the first quarter valued at $34,000. Whittier Trust Co. boosted its holdings in Henry Schein by 714.3% in the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after purchasing an additional 700 shares during the last quarter. Quarry LP purchased a new stake in Henry Schein in the first quarter valued at $71,000. Finally, UMB Bank n.a. boosted its holdings in Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after purchasing an additional 201 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Price Performance

NASDAQ:HSIC traded down $0.40 during trading hours on Friday, hitting $69.16. 627,768 shares of the stock were exchanged, compared to its average volume of 1,740,621. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The firm's fifty day moving average price is $69.44 and its 200 day moving average price is $69.53. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The company has a market cap of $8.39 billion, a P/E ratio of 22.28, a P/E/G ratio of 2.22 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. During the same quarter last year, the firm posted $1.23 earnings per share. Henry Schein's quarterly revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Ratings Changes

HSIC has been the topic of several recent research reports. Evercore ISI raised shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price target on the stock in a report on Tuesday, August 26th. Robert W. Baird reiterated a "neutral" rating and issued a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Baird R W lowered shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Sunday, September 7th. Finally, JPMorgan Chase & Co. lowered their target price on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. Five investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.